Results 41 to 50 of about 204,961 (215)
Nonlinear State Space Modeling and Control of the Impact of Patients' Modifiable Lifestyle Behaviors on the Emergence of Multiple Chronic Conditions [PDF]
arXiv, 2021 The emergence and progression of multiple chronic conditions (MCC) over time often form a dynamic network that depends on patient's modifiable risk factors and their interaction with non-modifiable risk factors and existing conditions. Continuous time Bayesian networks (CTBNs) are effective methods for modeling the complex network of MCC relationships ...
arxiv
Public Perspective on Hyperlipidemia Drugs and Sentiments About Hyperlipidemia on Twitter
Borneo Journal of Pharmacy, 2023 Hyperlipidemia is a non-communicable disease (NCD) caused by several factors, such as a person's socioeconomic status, culture, customs, habits, and lifestyle.
Murojil Hasan +2 more
doaj +2 more sources
Curcumin and saroglitazar attenuate diet-induced nonalcoholic steatohepatitis by activating the Nrf2 pathway and suppressing ERK1/2 signaling [PDF]
Iranian Journal of Basic Medical SciencesObjective(s): Non-alcoholic fatty liver disease (NAFLD) is a chronic steatohepatitis disorder. If left untreated, it can progress to hepatocellular carcinoma.
Reza Afarin +6 more
doaj +1 more source
Journal of Diabetes, 2019 Atherosclerotic cardiovascular disease (CVD) is on course to surpass infectious diseases as the leading cause of morbidity and mortality worldwide. Multiple risk factors are responsible for this trend including the increasing average life expectancy and ...
Joshua K Beverly, M. Budoff
semanticscholar +1 more source
Food & Nutrition Research, 2016 Background: Hyperlipidemia (HLP) is the primary risk factor of cardiovascular disease (CVD). Various factors, including genetics, physical inactivity, and daily nutritional habits, affect the prevalence of HLP.
Haitao Pan +8 more
doaj +1 more source
Up-regulated microRNA-185-3p inhibits the development of hyperlipidemia in rats
Kidney & Blood Pressure Research, 2022 Introduction: MicroRNA (miR)-185-3p functions in multiple cancers, while the underlying function of miR-185-3p in hyperlipidemia remained obscure. This research was conducted to unravel its function in hyperlipidemia development via modulating mastermind-
Hua Zhao, Yanbing Li
doaj +1 more source
Frontiers in Microbiology, 2019 Dysbiosis of the gut microbiota is a contributing factor for obesity-related metabolic diseases such as hyperglycemia and hyperlipidemia. Pharmacotherapy for metabolic diseases involves the modulation of gut microbiota, which is suggested to be a ...
Jiyeon Kim +6 more
semanticscholar +1 more source
Anti-Obese Effect of Glucosamine and Chitosan Oligosaccharide in High-Fat Diet-Induced Obese Rats
Marine Drugs, 2015 Objective: This study is to evaluate the anti-obese effects of glucosamine (GLC) and chitosan oligosaccharide (COS) on high-fat diet-induced obese rats. Methods: The rats were randomly divided into twelve groups: a normal diet group (NF), a high-fat diet
Lanlan Huang +8 more
doaj +1 more source
Emerging insights into the relationship between hyperlipidemia and the risk of diabetic retinopathy
Lipids in Health and Disease, 2020 Hyperlipidemia is correlated with a series of health problems. Notably, aside from its established role in promoting cardiovascular morbidity and mortality, hyperlipidemia has also been considered for modulating the risk and the severity of multiple ...
Yu-yu Chou, Jin Ma, X. Su, Y. Zhong
semanticscholar +1 more source
Circulation, 2016 The comorbidities of hypertension, diabetes mellitus, obesity, hyperlipidemia, and metabolic syndrome are common in patients with heart failure (HF) and affect clinical outcomes.1–3 Interestingly, although these comorbidities are associated with the ...
B. Bozkurt +11 more
semanticscholar +1 more source